The human Tousled-like kinases 1 and 2 (TLK) have been shown to be active during S phase of the cell cycle. TLK activity is rapidly suppressed by DNA damage and by inhibitors of replication. Here we report that the signal transduction pathway, which leads to transient suppression of TLK activity after the induction of double-strand breaks (DSBs) in the DNA, is dependent on the presence of a functional ataxia-telangiectasia-mutated kinase (ATM). Interestingly, we have discovered that rapid suppression of TLK activity after low doses of ultraviolet (UV) irradiation or aphidicolin-induced replication block is also ATM-dependent. The nature of the signal that triggers ATM-dependent downregulation of TLK activity after UVC and replication block remains unknown, but it is not due exclusively to DSBs in the DNA. We also demonstrate that TLK suppression is dependent on the presence of a functional Nijmegan Breakage Syndrome protein (NBS1). ATM-dependent phosphorylation of NBS1 is required for the suppression of TLK activity, indicating a role for NBS1 as an adaptor or scaffold in the ATM/TLK pathway. ATM does not phosphorylate TLK directly to regulate its activity, but Chk1 does phosphorylate TLK1 GST-fusion proteins in vitro. Using Chk1 siRNAs, we show that Chk1 is essential for the suppression of TLK activity after replication block, but that ATR, Chk2 and BRCA1 are dispensable for TLK suppression. Overall, we propose that ATM activation is not linked solely to DSBs and that ATM participates in initiating signaling pathways in response to replication block and UV-induced DNA damage.
Introduction
DNA replication is a cellular process whose fidelity is of the utmost importance for maintaining genome integrity. Cells are never more vulnerable to chromosome damage than while in the process of replication. The Sphase DNA damage checkpoint regulates DNA replication through a series of signaling events that coordinates the initiation of replicons and stabilization of replication forks with the detection and repair of DNA damage (Schar, 2001) . Ultimately, the S-phase checkpoint slows the rate of replication in response to DNA damage. Such checkpoints have been identified in yeast and mammalian cells. In yeast, signaling elements of this pathway include Rad3/Mec1 (PI-3 kinase-like kinases) and the downstream kinases, Chk1 and Cds1/Rad53, which are believed to interact directly with effectors of cell cycle progression (Zhou and Elledge, 2000) . These gene products have structural and functional equivalents in mammalian cells. Upstream signaling elements include the two PI-3 kinase family members, ataxiatelangiectasia mutated (ATM) (Shiloh and Rotman, 1996) and the ATM and Rad3-related protein (ATR) (Cliby et al., 1998) . Mammalian Chk1 (homologue of yeast Chk1) and Chk2 (homologue of yeast Cds1 and Rad53) act downstream of ATM and ATR to elicit cell cycle arrest Feijoo et al., 2001; Zhou et al., 2002) .
In mammalian cells, DNA damage incurred in S phase causes the inhibition of replication initiation and chain elongation. Such inhibition is dramatically reduced in ATM-null cells (derived from A-T patients) and occurs to a lesser extent in NBS1 cells (derived from Nijmegan Breakage Syndrome patients) (Painter and Young, 1980) , indicating a role for ATM and NBS1 in mediating the inhibition of replication after DNA damage. ATM-dependent phosphorylation of nibrin (NBS1) is required for the activation of the S-phase checkpoint (Gatei et al., 2000b) , but the other downstream effectors in the pathway are not known. Interestingly, the NBS1 protein seems to act as an adaptor for the phosphorylation of SMC1 Yazdi et al., 2002) , FANCD2 (Nakanishi et al., 2002) and Chk1 (Gatei et al., 2003) by ATM. Other studies have suggested that another ATM-dependent pathway (ATM/Chk2/cdc25A) is also required for the S-phase checkpoint. Here, ATM activates Chk2 which in turn phosphorylates cdc25A leading to its degradation with subsequent inhibition of cyclinE/cdk2 activity (Falck et al., 2001) . Other ATM targets, such as BRCA1 (Gatei et al., 2000a) , are also involved in the S-phase checkpoint and it is quite conceivable that ATM activates multiple pathways and targets cells to arrest in S phase after DNA damage. In this paper, we have investigated whether the human Tousled-like kinases, TLK1 and TLK2, which require ongoing DNA replication for their activity, are targets of checkpoint regulation (Sillje et al., 1999) .
The Tousled (TSL) gene was first identified in the plant, Arabidopsis thaliana, and recessive tsl mutants show a pleiotropic phenotype that includes abnormal flower development (Roe et al., 1993) . TSL encodes a serine/threonine kinase and it is not known what developmental genes it regulates. In humans, two Tousled-like kinases exist, TLK1 and TLK2, which are constitutively expressed but are activated during S phase of the cell cycle when replication is active. However, when DNA replication inhibitors or radiomimetric drugs are added to cells, TLK activity is rapidly downregulated (Sillje et al., 1999) . TLK1B was shown to phosphorylate histone H3 and to confer radioprotection in mouse mammary cells after g-irradiation, as detected by clonogenicity following irradiation . TLK also interacts with the chromatin assembly factor antisilencing function 1 (Asf1) and phosphorylates Asf1 during S phase (Sillje and Nigg, 2001) . Recent investigations have shown that Asf1 binds to the p60 subunit of hCAF1, but this association is not affected by the phosphorylation state of Asf1 (Mello et al., 2002) . Thus, a role for TLK has not been defined within the literature, but it may regulate the processing of newly replicated DNA and the formation of chromatin.
We report here that TLK is inhibited by both girradiation (ionizing radiation, IR) and long-term treatment with aphidicolin (both of which produce DNA double-strand breaks, DSBs) in an ATM-dependent manner. We show that NBS1 is also required for TLK inhibition after DNA damage, and most interestingly that the ATM phosphorylation site on NBS1 (serine 343) is required for the abrogation of TLK activity. In addition, inhibition of DNA replication, as induced by exposure to ultraviolet irradiation C (UVC) or short-term aphidicolin treatment of S-phase cells, leads to rapid loss of TLK activity in an ATM-, NBS1-and Chk1-dependent manner. Overall, the nature of the signal that triggers ATM-dependent downregulation of TLK activity after IR, UVC and replication block remains unknown, but DSBs are not the common denominator for these agents.
Materials and methods

Cell lines
Control, AT and NBS lymphoblastoid cell lines used for this study and were grown in RPMI with 10% fetal calf serum (FCS), penicillin (100 U/ml) and streptomycin (100 mg/ml). NBS-deficient fibroblasts were used which overexpress retroviral vectors containing the wild-type NBS1, S343A mutant NBS1 and the empty retroviral vector (LXIN) (as described in Gatei et al., 2000b) . The other adherent cell lines which were used in this study were the BRCA1-deficient cell line (HCC1937) and the Chk2-deficient cell line (HCT115), which were all cultured in RPMI with 10% FCS and antibiotics.
Lysate preparation, TLK immunoprecipitation, kinase assays and western blot analysis Cell lines were exposed to genotoxic agents (10-15 Gy of girradiation, 2 mm aphidicolin or UVC irradiation) and the cells harvested at the indicated time points. To prepare nuclei, cells were washed in PBS and then resuspended in homogenization buffer (25 mm HEPES, pH 7.4; 25 mm sucrose, 5 mm MgSO 4 , 1 mm EGTA, 50 mm NaF and protease inhibitors) and homogenized, using a dounce homogenizer. The extract was then centrifuged at 200 g for 20 min to obtain a nuclear pellet, which was then lysed using lysis Buffer (50 mm Tris; pH 7.4, 150 mm NaCl, 2 mm EDTA, 2 mm EGTA, 25 mm NaF, 0.2% Triton X-100, 0.3% NP40, 25 mm b-glycerophosphate and protease inhibitors) as described by Watters et al. (1997) .
(Note: for some experiments, total cell extract was obtained using lysis buffer containing 1% Tween-20 instead of Triton X-100 and NP40 as described in figure legends). Nuclear extract (30 mg) was loaded per lane for Western blots to detect protein levels on 6 or 8% SDS-PAGE gels. After separation, the proteins were transferred onto nitrocellulose. The nitrocellulose blots were then blocked in 5% milk in phosphatebuffered saline (PBST) (with 0.05% Tween-20) and incubated with antibody diluted in 5% milk-PBST overnight at 41C. Immunoprecipitation of TLK and Western bloting were performed using anti-TLKN antibody (Sillje et al., 1999) which recognizes both TLK1 and TLK2.
Immunoprecipitation was performed with nuclear extracts after they were precleared with protein A beads for 1 h at 41C. Anti-TLKN antibody was incubated with the precleared lysate overnight at 41C on a rotating wheel and then protein A beads were added for 2 h. The beads were then washed three times in lysis buffer and once in kinase buffer (50 mm Tris; pH 7.4, 10 mm MgCl 2 and 1 mm DTT). As stated in figure legends, immunoprecipitates were also washed once in 0.5 m LiCl 2 (prior to being washed in kinase buffer) to reduce nonspecific protein interaction with immunoprecipitated TLK. The immunoprecipitated TLK was then incubated with kinase mix (kinase buffer and 10 mCi of [g-32 P]ATP) for 30 min at 301C and analysed by SDS-PAGE followed by autoradiography. Myelin basic protein (MBP) (5 mg) was added to some kinase reactions. TLK specific activity (level of autophosphorylation/ protein or level of MBP phosphorylation/protein) was determined by densitometry analysis (Molecular Dynamics) and quantitated using Imagequant software. Other antibodies used in this study include: anti-NBS1 antisera from Novus, anti-Ser-15 p53 antibody from New England Biolabs, anti-p53 antibody from Novacastra, anti-ATR antibody from Oncogene and anti-Chk1 antibody from Santa Cruz.
Recombinant proteins
GST fusion peptides of TLK1 (Accession number AF162666) were prepared by cloning PCR products of the TLK1 gene into the pGEX2 T vector and the GST-TLK fusion proteins were purified as described previously (Frangioni and Neel, 1993) . Primers contained either 5 0 ends with BamH1 or EcoR1 sites for cloning of each TLK1 PCR fragment into the BamH1 and EcoR1 sites of the pGex2 T vector (Pharmacia). The four TLK1 GST-fusion peptides made in this manner correspond to amino acids 1-321 (T1), 317-480 (T2), 480-616 (T3) and 606-718 (T4). The GST-fusion fragments were used in Chk1 and ATM kinase assays as described in Khanna et al. (1998) , and Zhao and Piwnica-Worms (2001) .
Transfection of cells with the pSuper vector for the production of small interfering RNAs
The pSuper vector was obtained from Reuven Agami (Brummelkamp et al., 2002) and used to clone the Chk1 sequence (5 0 -CAACTTGCTGTGAATAGAG-3 0 ) and the ATR sequence (5 0 -GGAGATTTCCTGAGCATGT-3 0 ) as described in Brummelkamp et al. (2002) for the production of small interfering RNAs, which prevent protein production from the mRNA transcripts. The pSuper vector (empty), ATR-pSuper and Chk1-pSuper plasmids were transfected into 293 T cells using electroporation and 24 h after transfection, the cells were treated with aphidicolin as described above. The activity of TLK in transfected cells was determined after aphidicolin treatment. The downregulation of Chk1 and ATR expression in transfected cells was assessed by Western blotting with anti-Chk1 monoclonal (Santa Cruz) and anti-ATR antibody (Oncogene).
Results
Tlk activity is transiently inhibited following g-irradiation in an ATM-dependent manner TLK1 and 2 have been shown to be inhibited by treatment of cells with a number of DNA damaging agents such as bleomycin and methyl methanesulfonate as well as by blockers of DNA replication (Sillje et al., 1999) . In order to understand the mechanism of inactivation of TLK 1 and 2, we initially evaluated the suppression of TLK activity in response to g-irradiation. TLK activity was assayed after the immunoprecipitation of both TLK1 and TLK2 with anti-TLKN antibody (Sillje et al., 1999) , using autophosphorylation of TLKs or MBP as substrate. The incorporation of label into TLK immunoprecipitates is due to TLK autophosphorylation but not due to co-precipitating kinases as the kinase-dead TLK does not incorporate radiolabel under similar assay conditions (Sillje et al., 1999) . Furthermore, Sillje et al. (1999) have shown that TLK autophosphorylation is an adequate measure for TLK activity as it mirrors MBP phosphorylation. MBP phosphorylation was compared with TLK autophosphorylation at 40 min and 3 h after exposure of the control lymphoblastoid cell line (C2ABR) to 15 Gy of girradiation. Both TLK autophosphorylation and MBP phosphorylation were found to be comparably reduced (55%), 40 min after exposure to irradiation ( Figure 1a ). Thus, both autophosphorylation and MBP phosphorylation may be used to investigate TLK regulation. We found that TLK autophosphorylation was clearer and often slightly more pronounced than MBP phosphorylation and have used autophosphorylation activity for most of this study. Interestingly, TLK inhibition by girradiation was transient as activity returned to unirradiated levels 3 h after irradiation exposure ( Figure 1a ). This kinetics of inhibition of TLK after irradiation parallels the kinetics of suppression of DNA synthesis after g-irradiation (Zdzienicka et al., 1989; Zhou et al., 2002) . Cells lacking ATM function lack this irradiationinduced suppression of DNA synthesis. Furthermore, virtually all responses to g-irradiation are mediated by the phosphoinositide 3-kinase related kinase, ATM . This prompted us to investigate whether ATM is regulating TLK activity after DNA damage.
To test whether TLK suppression was ATM-dependent, TLK activity was examined in two normal lymphoblastoid cell lines (C2ABR and C3ABR) as controls, and in two cell lines derived from patients with AT (ataxia-telangiectasia -AT1ABR and L3). We detected a significant increase in TLK suppression at 40 min after irradiation exposure (15 Gy) of control cell lines ( Figure 1b) . However, the ATM-deficient cell lines (0) and left for 40 min or 3 h prior to lysis. TLK was immunoprecipitated from C2ABR nuclear extracts using the anti-TLKN antibody and incubated for 30 min with MBP at 371C in kinase mix. The kinase mix was then separated by 12% PAGE, and incorporation of radiolabel in MBP and TLK was detected by exposure to film (top panels). Equal protein from nuclear extracts was separated by 6% PAGE, transferred onto nitrocellulose and developed using anti-TLKN antibody (bottom panel). The IgG immunoprecipitation (right panels) shows no nonspecific TLK activity. Specific activity of TLK was calculated by densitometry of the phosphoband and the TLK protein band using Image Quant software. The ratio of phosphoband/TLK protein band gives a value of specific activity. The per cent activity is calculated by dividing the specific activity of the treated sample by the specific activity of the untreated, control sample and is shown below the bottom panel. (b) The lymphoblastoid lines C3ABR and C2ABR (both wild-type ATM) and L3 and AT1ABR (both ATM-deficient) were irradiated with 15 Gy of g-irradiation ( þ ), or not (À), and then lysed 40 min later for TLK immunoprecipitation and kinase assay to measure TLK autophosphorylation. Protein levels were determined by staining Western blots of cell extracts with anti-TLKN (bottom panels) had no decrease in TLK activity with the same irradiation treatment (Figure 1b) , indicating that the transient decrease in TLK activity following g-irradiation is ATM-dependent. This suppression of TLK activity could be due to the absence of ongoing DNA replication in control cells as TLK activity has previously been shown to be cell cycle regulated and linked to ongoing DNA synthesis. Cells lacking functional ATM lack this irradiation-induced suppression of DNA synthesis. Therefore, it is highly likely that ongoing DNA replication in AT cells might keep TLK active. To rule out this possibility, we used overnight treatment of cells with aphidicolin to totally block DNA synthesis and to cause DNA damage at the same time.
Both long-and short-term aphidicolin treatment inhibits TLK via an ATM-dependent pathway Sillje et al. (1999) had previously shown that replication inhibition of S-phase cells by aphidicolin treatment leads to a rapid suppression of TLK activity, which sustains as long as aphidicolin is present. It is also known that cells treated for over 6 h with aphidicolin will have a high number of DNA DSBs that result from the collapse of replication forks (Saintigny et al., 2001) . We were interested to determine if overnight treatment of cells with aphidicolin (which is routinely used to synchronize cells at G1/S boundary) results in an ATM-dependent inhibition of TLK activity similar to that of the TLK response to g-irradiation-induced double-strand DNA breaks. Again, we compared AT cell lines with wild-type counterparts to perform this study and treated the cells for at least 15 h (overnight) with aphidicolin prior to harvest. Overnight aphidicolin treatment blocks AT cells in G1/Early S and therefore stops DNA replication in AT cells, like it does in normal cells (Beamish et al., 1996; and data not shown) . Figure 2a and b shows that in the control cell line (C2ABR), aphidicolin inhibits TLK activity but does not inhibit the activity of TLK in the two AT cell lines (L3 and AT1ABR). Of interest, the TLK protein band in Figure 2a is notably shifted down following overnight aphidicolin treatment in both wildtype and ATM-deficient cells. This increase in TLK mobility could be due to an ATM-independent dephosphorylation of TLK induced by aphidicolin. However, there is no apparent relation between TLK mobility and TLK activity in the data of Figure 2a and phosphatase treatment of TLK has previously been shown not to reduce its ability to phosphorylate MBP (Sillje et al., 1999) . These experiments, in combination with those shown in Figure 1 , indicate that inducers of doublestrand DNA breaks suppress TLK activity via an ATMdependent pathway. This work also suggests that TLK suppression is related to the checkpoint response rather than a consequence of absence of ongoing DNA replication.
To further investigate whether TLK suppression is related to the S-phase checkpoint (replication checkpoint), we decided to assay TLK activity after replication block. We chose a short-term (20 min) aphidicolin treatment of mid-S-phase cells to block DNA replication. Previous studies have shown that aphidicolin inhibits the processive elongation of nascent DNA strands during replication by inhibiting the DNA polymerase activity (Nethanel and Kaufmann, 1990) , resulting in fork arrest. As shown in Figure 2b , TLK activity as measured by its autophosphorylation, fell substantially within 20 min after the addition of aphidicolin to mid-S-phase control cells (C2ABR), but not in ATM-deficient cells. To verify that TLK autophosphorylation is a specific measure of TLK activity after aphidicolin treatment, and to check that , L3 (ATM-deficient) and AT1ABR (ATM-deficient) were treated with 2 mm aphidicolin overnight ( þ ) or not (À). Nuclear lysates were prepared and TLK was immunoprecipitated for kinase assays. (b) C2ABR and L3 were treated with aphidicolin overnight as in (a) and then were released for 4 h (Rel.) (mid-S-phase cells) or not (Aph.). Mid-S-phase cells were treated for 20 min with 2 mm aphidicolin (20 0 ) before nuclear extracts were made for TLKN immunoprecipitation and kinase assay for autophosphorylation. (c) Nuclear lysates of S-phase cells (Rel.) and aphidicolin-treated Sphase cells (20 0 ) were prepared using lysis buffer containing 1% Tween-20 and TLK immunoprecipitated to assay phosphorylation of both MBP and TLK. The immunoprecipitated TLK was washed with high salt (0.5 m LiCl 2 ) prior to being washed in kinase buffer to rule out co-precipitation of other proteins in TLK immunoprecipitates. Levels of TLK were detected using Western blots of immunoprecipitated TLK, developed with anti-TLKN antibody (bottom panel) there are no co-precipitating kinases or phosphatases interfering with the assay, TLK immunoprecipitates were obtained from nuclear extracts containing 1% Tween-20 and were washed with high amounts of salt (0.5 m lithium chloride) (Khanna et al., 1998) before kinase assay. Figure 2c shows that both MBP and TLK phosphorylation is suppressed similarly when mid-Sphase cells are treated with aphidicolin, and that autophosphorylation is a true measure of TLK kinase activity under these conditions. These results suggest that the suppression of TLK activity during mid-S phase by aphidicolin is predominantly mediated by ATM.
Low doses of UV irradiation inhibits TLK in an ATMdependent manner
To verify the role of ATM in activating a checkpoint response to replication block, the effect of UV irradiation on TLK activity was investigated. The ability of cells derived from AT patients to retain normal resistance to UV irradiation has been attributed to the presence of a functional ATR kinase, which shares overlapping specificity with ATM in vitro, but is activated in response to different damaging agents in vivo, including IR, UV and replication block (Cliby et al., 1998; Tibbetts et al., 1999 Tibbetts et al., , 2000 Zhou et al., 2002) . However, other reports have shown that AT cells are defective in UVC-induced alterations in the DNA replication complex (Oakley et al., 2001) and have a decreased ability to inhibit replication after UVC exposure (Kaufmann, 1995) . Consistent with this, we have previously shown that low-dose, UVC-induced, BRCA1 phosphorylation is dependent on ATM (Gatei et al., 2000a) , while at high doses of UV, ATR appears to be primarily responsible for the BRCA1 phosphorylation (Gatei et al., 2001) . TLK activity was therefore assessed in ATM-positive and ATM-deficient cells after exposure to low (22 J/m 2 ) doses of UVC. TLK activity was suppressed dramatically (60% inhibition) within 15 min of UVC (22 J/m 2 ) treatment of control (C2ABR), but not AT cells (L3 and AT1ABR) (Figure 3a) . As with g-irradiation, the suppression of TLK was transient after UV irradiation of control cells as TLK activity was increased from 41% (at 15 min) to 74% of the original activity 60 min after UVC irradiation. These results indicated that ATM was activated by UVC irradiation and that it was acting quickly to inhibit TLK activity. To verify the defect in UVC response of TLK in AT cells, p53 phosphorylation status was investigated using a phosphospecific antibody (phospho-Ser 15) that recognizes the ATM and ATR phosphorylation site on p53. At low doses (22 J/m 2 ) of (0) and then incubated for 15 or 60 min when nuclear extracts were prepared for TLKN immunoprecipitation and in vitro kinase assay of autophosphorylation activity (top panel). Levels of immunoprecipitated TLK were detected using Western blots developed with anti-TLKN antibody (bottom panel). Specific activity of TLK was calculated as described in Figure 1a. (b, c) Wild-type (C2ABR and C3ABR) and ATM-deficient lymphoblastoid cell lines (L3 and AT1ABR) were used to investigate the phosphorylation of p53 after exposure to 22 J/m 2 (b) or 80 J/m 2 (c) of UVC. Antiphospho p53 antibody, specific for phosphorylated Ser-15 of p53, was used to stain Western blots of nuclear extracts of the lymphoblastoid lines at the indicated times after UVC exposure (top panels). These blots were then stripped and stained with anti-p53 antibody so that p53 protein levels could be determined (bottom panels) TLK activity requires ATM, NBS1 and Chk1 DR Krause et al UVC, p53 phosphorylation does not increase significantly in the AT cell lines until 60 min after irradiation. However, control cells have increased p53 phosphorylation within 30 min (Figure 3b ). At higher doses of UVC (80 J/m 2 ), an ATM-independent pathway, likely mediated by ATR, appears to be responsible for p53 phosphorylation since both AT and control cells have increased p53 phosphorylation at 30 min after irradiation (Figure 3c and Tibbetts et al., 2000) . These results confirm that ATM contributes significantly to the suppression of TLK activity in response to replication block.
TLK inhibition requires an intact NBS1
The above results suggest that the irradiation-induced inhibition of TLK activity could be due to the replication checkpoint response. Therefore, other cell types lacking the suppression of DNA synthesis after irradiation were investigated for a defect in TLK inactivation. One of the downstream targets of ATM, NBS1 (product of the gene defective in Nijmegan Breakage Syndrome), is also required for the suppression of DNA synthesis after irradiation. TLK activity was assayed in the NBS1-deficient lymphoblastoid line (NBS03LA) derived from NBS patients, following overnight aphidicolin treatment (Figure 4a ). TLK autophosphorylation was monitored and the NBS03LA cell line was found to be defective (only 20% reduction in TLK activity) in suppressing TLK activity compared to the wild-type C2ABR (Figure 4a ). To extend this concept beyond simple correlation, we used an NBS1-deficient fibroblast cell line that was stably complemented with either an empty retroviral vector (LXIN), a wild-type NBS1 or an NBS1 with serine 343 (ATM phosphorylation site) mutated to alanine (Gatei et al., 2000b) . Previous studies have shown that complementation with wild-type NBS1 restored the irradiationinduced suppression of DNA synthesis, while complementation with the S343 A NBS1, failed to restore this defect (Lim et al., 2000) . NBS1 cells infected with either the empty vector alone (LXIN), or the S343A NBS1 mutant, failed to exhibit a decline in TLK activity after irradiation (Figure 4b ). In contrast, NBS1 cells complemented with wild-type NBS1, which restores suppression of DNA synthesis, showed a significant reduction (58% suppression) in TLK activity after irradiation (Figure 4b ). Thus, a more secure link is established between the intra S-phase checkpoint response and suppression of TLK activity. It should be noted that basal TLK activity was not always lower in the LXIN fibroblasts when compared to the NBS1-or S343A-infected fibroblasts (Figure 4b) . Also, the nibrindeficient lymphoblast cell line, NBS03LA, often had more basal TLK activity than the control C2ABR cell line (data not shown). This suggests that the regulation of TLK activity is irregular in the absence of NBS1.
It was then decided to investigate whether NBS1 was required for the inhibition of TLK activity after replication arrest with short-term aphidicolin treatment of S-phase cells. The NBS1-deficient cell line failed to show any inhibition of TLK activity after aphidicolin Figure 4 TLK inhibition requires an intact NBS1. (a) The NBS1-deficient lymphoblastoid cell line (NBS03LA) and the control C2ABR were treated with 2 mm aphidicolin overnight and TLK kinase assays were performed on immunoprecipitated nuclear TLK as described in Figure 2. (b) NBS1-deficient fibroblasts infected with the retroviral plasmid LXIN, the wild-type NBS1 (NBS1) and the S343A NBS1 were g-irradiated with 10 Gy, or not, and left for 1 h before nuclear extracts were made for TLK immunoprecipitation and kinase assay. (c) The NBS1-deficient lymphoblastoid cell line (NBS03LA), the BRCA1-deficient fibroblast cell line (HCC1937) and normal lymphoblastoid cell line (C2ABR) were treated with aphidicolin overnight as in (a) and then released for 4 h (Rel.). Mid-Sphase cells were treated for 20 min with 2 mm aphidicolin (20 0 ) before nuclear extracts were made for TLKN immunoprecipitation and kinase assay. (d) TLK was immunoprecipitated from the nuclear extracts of C2ABR cells using anti-TLKN antibody (TLKN) or rabbit IgG (IgG, as control). Cells were unsynchronized (TLKN), irradiated (g), treated with aphidicolin overnight (Aph.) or released (Rel). The immune complexes were separated by 6% PAGE and transferred onto nitrocellulose for staining with anti-NBS1. Western blots of immunoprecipitated TLK are shown in the bottom panels TLK activity requires ATM, NBS1 and Chk1 DR Krause et al (20 min) treatment of mid-S-phase cells (Figure 4c ), although TLK was markedly inhibited in control cells. These results place NBS1 downstream of ATM but upstream of TLK and provide evidence that NBS1 and TLK are linked in their roles in responding to the replication checkpoint that occurs when DNA synthesis is suppressed. BRCA1 is another component of the ATM signaling pathway and it has been shown to be involved in regulating the intra-S-phase checkpoint . The BRCA1-associated complex (BASC) has been shown to contain Mre11 and NBS1 as well as other proteins involved in replication and DNA maintenance (Wang et al., 2000) . To determine if BRCA1 was required for the inhibition of TLK after replication block, a BRCA1-deficient cell line (HCC1937) was used to assay TLK suppression after short-term aphidicolin block of mid-S-phase cells. TLK activity was suppressed after 20 min of aphidicolin treatment of S-phase cells in the absence of a functional BRCA1 (Figure 4c ). This suggests that BRCA1 is not required for the ATMmediated suppression of TLK after replication block.
(Note: Due to the low levels of TLK activity in non-Sphase HCC1937 cells, TLK suppression could not be investigated after irradiation treatment or overnight aphidicolin treatment of unsynchronized BRCA1 null cells.) To determine if TLK was part of a complex that binds to nibrin, we stained Western blots of immunoprecipitated TLK with anti-NBS1 and showed that NBS1 does co-immunoprecipitate with TLK ( Figure 4d ). The amount of nibrin co-precipitating with TLK did not change significantly after DNA damage or replication block. About 10-20% of the total nibrin was bound to TLK in untreated cells, as determined by comparing the amount of nibrin immunoprecipitated by antinibrin antibody (using 1/5th the amount of protein used for anti-TLKN immunoprecipitation) with the amount of nibrin immunoprecipitated using anti-TLKN (data not shown). Other members of the DNA damage response pathway, like Rad51, were not detected by immunoblot in immunoprecipitates of TLK (data not shown). Together, these results confirm that TLK and NBS1 are components of a complex that acts downstream of ATM.
TLK is not a direct target of ATM but Chk1 can phosphorylate TLK GST-fusion proteins in vitro
To examine whether ATM is modulating TLK activity directly, or indirectly through checkpoint kinases (Chk1/Chk2), we constructed a series of recombinant GST-TLK1 subfragments (T1-T4) covering the entire open reading frame as described in Materials and methods (Figure 5a ). We used these as substrates for in vitro kinase reactions of immunoprecipitated ATM, with or without prior exposure to 10 Gy of irradiation. GST-p53 (1-40) served as the positive control for ATM kinase assays and was efficiently phosphorylated by ATM. However, GST-TLK subfragment 3 (T3), which contains an ATM phosphorylation site (MXLTSQ) that is present in both TLK1 (S580) and TLK2 (S612), was not phosphorylated by ATM (Figure 5b) . The other three TLK1 subfragments were also used as substrates in an ATM kinase assay and were not phosphorylated by ATM and a full-length mutant TLK (S580A-putative ATM site that was not able to be phosphorylated in vitro) was suppressed after DNA damage like wild-type TLK1 (data not shown). These results suggest that ATM is not directly phosphorylating TLK.
TLK1 and TLK2 both possess Chk2/Chk1 phosphorylation motifs (RXXS), and we wanted to determine if these checkpoint kinases regulated their activity via phosphorylation. Chk2 has been identified as a checkpoint kinase downstream of ATM/NBS1 and is activated following DNA damage in mammalian cells (Buscemi et al., 2001) . However, we failed to see in vitro phosphorylation of TLK by Chk2 (data not shown) and the Chk2-deficient colon carcinoma cell line HCT115 possessed normal kinetics of inhibition of TLK activity after both long and short aphidicolin treatments ( Figure 6 ). Another downstream component of the ATM/ATR pathways is the checkpoint kinase, Chk1 (Gatei et al., 2003) . Chk1 activity has been shown to be linked to DNA replication and to the intra-S-phase checkpoint (Boddy et al., 1998; Brondello et al., 1999; Graves et al., 2000) . The above results suggest that the suppression of TLK activity is within the S-phase checkpoint response, like Chk1 (Gatei et al., 2003) .
To investigate whether Chk1 can directly phosphorylate TLK in vitro, the four GST-fusion proteins of TLK GST-TLK1 fusion proteins were purified and fragment T3, which contains an ATM phosphorylation motif (SQ), was incubated with immunoprecipitated ATM in an in vitro kinase assay (lane #3.), as described in Gatei et al. (2000a) . GST-alone (lane #1.) and GST-P53 fragment (amino acids 1-40) (lane #2.) were used as negative and positive controls, respectively, for ATM activity. Total cell extract was obtained from C3ABR cells that were either irradiated with 10 Gy of g-irradiation or not and then lysed after 30 min. Sheep anti-ATM was used to immunoprecipitate ATM and the peptides were incubated with ATM for 40 min at 301C in ATM kinase buffer (Gatei et al., 2000a) . The kinase reaction was stopped by boiling in 5 Â laemmeli buffer. SDS-PAGE (10%) was used to resolve the GST peptides and this was stained with Coomassie blue prior to being dried down onto Whatman paper. The top panel shows the Coomassie blue-stained gel and the bottom panel shows the autoradiograph of the same gel (T1-T4) were incubated with immunoprecipitated Chk1 for 30 min at 301C in Chk1 kinase buffer (Figure 7a ). Chk1 did not phosphorylate GST alone nor T1 or T3; however, robust phosphorylation of T2 and T4 occurred. The Chk1 substrate peptide was used as a positive control and its phosphorylation compared favorably with that of T2 and T4 phosphorylation. T4 has a serine that exists within a putative Chk1 phosphorylation site motif (Figure 5a -RXXS) as described by O'Neill et al. (2002) . This serine is residue 695, which lies near the C-terminus and in the kinase domain of TLK1 and is conserved in both TLK1 and TLK2. However, there is no Chk1 phosphorylation consensus motif in T2, but serine 444 is a good candidate for Chk1 phosphorylation as it is surrounded by positively charged residues; however, it is not conserved in both TLK1 and TLK2. Work is in progress to mutate serine 695 to alanine to determine its effect on TLK activity. To further define the role of Chk1 in regulating TLK activity a Chk1 inhibitor (SB218078) was used to determine if suppression of TLK activity after replication block or DNA damage could be abrogated by inhibiting Chk1 activity Figure 6 Chk2 is not required for TLK suppression after replication block or DBSs. The Chk2-deficient colon carcinoma cell line (HCT115) was treated overnight with 2 mm aphidicolin (Aph) and then released for 4 h into mid-S phase of the cell cycle. Mid-S-phase cells were either mock-treated (Rel.) or treated with aphidicolin for 20 min (20'). Nuclear lysates were then prepared for TLKN immunoprecipitation and in vitro kinase assay of TLK autophosphorylation (top panel). Western blots were stained with anti-TLKN to determine the amount of immunoprecipitated TLK (bottom panel) Figure 7 Chk1 phosphorylates GST-fusion fragments of TLK1 in vitro. (a) Chk1 was immunoprecipitated from C3ABR cells using anti-Chk1 antibodies and then incubated with GST alone, GST-TLK1 peptides (T1-T4) or a GST-cdc25C fusion peptide for 30 min in Chk1 kinase buffer at 301C. The peptides were then separated by 12% PAGE, stained with Coomassie blue and developed under X-ray film (b) TLK was immunoprecipitated from nuclear extracts of C2ABR cells using anti-TLKN antibody and then incubated for 5 min at room temperature with 100, 400 nm of SB218078 or not (0) prior to the addition of kinase buffer and ATP (as described in Zhao and Piwnica-Worms (2001) ). The kinase assays were then stopped and resolved by 8% SDS-PAGE, dried onto Whatman paper and developed against X-ray film (top panel). Western blots of the kinase assays were performed and stained with anti-TLKN (bottom panel) (Jackson et al., 2000) . As a control, the effect of 100 nm SB218078 on TLK activity in vitro was determined and since inhibition of TLK activity was observed in vitro ( Figure 7b , greater than 50% suppression), the drug could not be used to specifically inhibit Chk1 function in vivo. These results have important consequences for drug development designed to inhibit Chk1 and other checkpoint kinases.
Small interfering RNAs (siRNAs) to Chk1 but not ATR abrogate TLK suppression after replication block
To further verify the role of Chk1 in regulating TLK activity, an antisense strategy was tested using the pSuper vector to clone in short oligos for the production of small interfering RNAs (Brummelkamp et al., 2002) , which suppress Chk1 and ATR protein synthesis. ATR has been described as the activating kinase for Chk1 in response to replication block (Hekmat-Nejad et al., 2000; Zhao and Piwnica-Worms, 2001 ). Therefore, ATR could be regulating the suppression of TLK after replication block. When Chk1 protein was depleted in cells transfected with pSuper-Chk1, TLK activity was not suppressed after short aphidicolin treatment of Sphase cells (Figure 8a, b) . However, when ATR was depleted (Figure 8c ) in the cells transfected with pSuper-ATR, the extent of suppression of TLK activity was quite comparable to those cells transfected with empty pSuper vector (Figure 8a ). These results verify that Chk1 does regulate TLK activity and is required for its suppression after replication block, but that ATR is not required for TLK suppression. Together, these results show that ATM, but not ATR, is upstream of Chk1 and TLK in the checkpoint pathway which is activated after replication block.
Discussion
TLKs have maximal activity during S phase in proliferating human cells, but are quickly inactivated in response to DNA-damaging agents and replication inhibitors (Sillje et al., 1999) . The mechanism through which TLKs are inactivated and the molecules which mediate TLK inhibition have yet to be identified. Here, we have identified the signal transduction pathway that mediates TLK inhibition following the activation of either DNA damage or DNA replication checkpoints. The DNA damage checkpoint can be classified into G1/ S, S and G2/M checkpoints, so named according to the cell cycle transition they regulate. DNA damage incurred during the G1 or G2 phases of the cell cycle leads to growth arrest at the G1/S and G2/M boundaries, respectively. In contrast, genotoxic stress during S phase results in the transient inhibition of DNA synthesis and suppression of mitotic entry, which is commonly referred to as the DNA replication checkpoint (Canman, 2001) . The replication checkpoint also prevents mitosis if DNA replication is inhibited by UV irradiation, g-irradiation, aphidicolin (inhibits polymerase activity) or thymidine (depletes dNTP pools) treatment.
Here, we provide evidence that the signaling pathway that leads to the suppression of TLK activity after irradiation damage and after replication block is dependent on the presence of functional ATM and NBS1 protein. Earlier literature has documented a role for ATM and NBS1 in the intra-S-phase checkpoint after irradiation, as determined by radioresistant DNA synthesis in ATM-or NBS1-deficient cells. However, it is widely believed that ATM does not operate in signaling pathways initiated by incomplete DNA replication or stalled replication forks. This is based on the studies that show the abolition of rapid phosphorylation of ATM targets in AT cells in response to IR, but not UVC or hydroxyurea treatment. Interestingly, most of these studies have used a very high dose of UVC (80 J/m 2 ) or UVB, including our own earlier studies (Khanna and Lavin, 1993) . Recently, we have demonstrated that lower UVC doses are required to detect ATM-dependent phosphorylation of BRCA1 (Gatei et al., 2001) . At lower doses of UVC (20 J/m 2 ), rapid phosphorylation of BRCA1 (within 15-30 min) was ATM-dependent. However, at later time points (after 60 min) or at higher doses of UVC (80 J/m 2 ), BRCA1 phosphorylation was mediated by ATR (Gatei et al., 2000a (Gatei et al., , 2001 . Analogous results were obtained in the present study with p53 phosphorylation after UVC exposure (Figure 3) . The use of lower doses of UVC to damage DNA exposes the deficiencies in AT cells in responding to other damaging agents that induce replication block. In other words, by hyperactivating the checkpoint machinery with high doses of UVC (inducing large amounts of DNA damage), the requirement for ATM in the signaling pathway is reduced. In this scenario, absolute requirement of ATM and NBS1 for the phosphorylation of SMC1 Yazdi et al., 2002) or Chk1 (Gatei et al., 2003) is lost when cells are treated with high doses (20 Gy) of IR.
The nature of the signal that triggers ATM-dependent downregulation of TLK after IR (which induces DSBs), UVC (which leads to the formation of pyrimidine dimers) and aphidicolin (initially blocks DNA replication but at later time (after 6 h) also induces DSB's) remains unknown, but is not due exclusively to DSBs. This finding is supported by a recent report that ATM autophosphorylation and activation is increased after changes in chromatin structure, as induced by genotoxic agents other than g-irradiation (Bakkenist and Kastan, 2003) . Nonetheless, it appears that suppression of TLK activity is independent of the initiating lesion. The transient suppression of TLK in response to IR and UV does coincide with the published kinetics of DNA synthesis inhibition by these agents. However, the suppression of TLK is not a consequence of the absence of ongoing DNA synthesis, but is a result of the damage-induced checkpoint response as ATM-and NBS1-deficient cells fail to suppress TLK activity when replication is stopped by aphidicolin treatment. Thus, it appears that the suppression of TLK activity requires a checkpoint pathway dependent on the presence of functional ATM and NBS1.
So far the literature has documented a role for ATM in the intra-S-phase checkpoint and has shown functional interplay between Chk2, BRCA1 and NBS1 as the downstream mediators of ATM, which lead to the inhibition of S-phase DNA synthesis (Falck et al., 2001 ). Here, we have shown that TLK suppression is ATMand NBS1-dependent but does not require Chk2. To support our finding, recent investigations have shown that Chk2 is not downstream of NBS1 and that the ATM/NBS1 pathway is divergent to the ATM/Chk2/ Cdc25A pathway for the intra-S-phase checkpoint (Yazdi et al., 2002) . The phosphorylation of NBS1 at serine 343 by ATM does not seem to be required for the formation of the Mre11/Rad50/NBS1 complex nor for the phosphorylation of the downstream targets of ATM, such as BRCA1 and p53 (Gatei et al., 2000b) . However, like SMC1 Yazdi et al., 2002) , and Chk1 (Gatei et al., 2003) , TLK does require a functional NBS1 for suppression after DNA damage.
Our data suggest that ATM does not phosphorylate TLK directly to suppress its activity. However, Chk1 is required for the suppression of TLK activity after replication block but ATR, Chk2 and BRCA1 are dispensable for TLK suppression. Overall, TLK is a new member of the ATM signaling pathway that is inhibited following the activation of DNA damage and replication block, regardless of the initiating agent. Owing to the lack of knowledge about the substrates and function of TLK, it is difficult to speculate on the effect of TLK suppression in regulating cellular responses to DNA damage. Future investigations will attempt to determine the role of TLK in replication and investigate whether lack of suppression of TLK activity after DNA damage contributes to the radioresistant DNA synthesis phenotype, characteristic of ATM-, NBS1-, and Chk1-deficient cells and which results in genome instability.
